baber/WOPTO huggingface dataset:
Patent CA-3153368-A1 (CA)
Title: Finger tab container carrier
Inventor: OLSEN ROBERT C
IPC: B65D71/50
Filed: 2020-10-07
Abstract: A container carrier (100) for unitizing a plurality of containers (102) that includes a plurality of flexible bands (104) forming an array of container receiving apertures (106), the array arranged in longitudinal rows and transverse ranks. A generally rectangular shaped intermediate aperture (108) is formed between each pair of container receiving apertures, wherein at least two sides of the intermediate aperture are concave, forming convex tabs protruding inward to the intermediate apertures. The resulting carrier is capable of unitizing a variety of containers in a tight multipackage with finger tabs to make carrying the multipackage much easier.
Patent CA-3154973-A1 (CA)
Title: Composes pour l'induction d'une tolerance immunitaire specifique d'un antigene
Inventor: Kontos Stephan
IPC: A61K47/58
Filed: 2020-09-18
Abstract: L'invention concerne des composés pour l'induction d'une tolérance immunitaire spécifique de l'antigène chez un sujet, les composés comprenant un antigène, un lieur polymère et une fraction de ciblage du foie, le lieur polymère comprenant une unité d'extrémité terminale dépourvue d'un dithioester et d'un dithiobenzoate et l'unité d'extrémité terminale conférant une stabilité améliorée au composé lorsqu'elle est en solution.
Patent CA-3156111-A1 (CA)
Title: System and methods for the efficient identification and extraction of sequence paths in genome graphs
Inventor: CHEUNG YEE HIM
IPC: G16B30/20
Filed: 2020-09-29
Abstract: A method for storing, by a processor, a genome graph representing a plurality of individual genomes, including: storing a linear representation of a reference genome in a data storage; receiving a first genome; identifying variations in the first genome from the reference genome; generating graph edges for each variation in the first genome from the reference genome; generating for each generated graph edge: an edge identifier that uniquely identifies the current edge in the genome graph; a start edge identifier that identifies the edge from which the current edge branches out; a start position that indicates the position on the start edge that serves as an anchoring point for the current edge; an end edge identifier that identifies the edge into which the current edge joins in; an end position that indicates the position on the end edge that serves as an anchoring point for the current edge; and a sequence indicating the nucleotide sequence of the current edge; and storing the edge identifier, start edge identifier, start position, end edge identifier, end edge position, and sequence for each generated graph edge in the data storage. Based on this genome graph data structure, we further propose a scheme for specifying a path, which may traverse one or more edges, and the ways to extend existing genomic data formats such as SAM, VCF and MPEG-G to support the use of genome graph reference using our proposed coordinate system.
Patent CA-3157419-A1 (CA)
Inventor: LIN I-CHIEN
IPC: D03D15/54
Filed: 2022-04-28
Abstract: The disclosure provides a fabric suitable for an inner light cloth of advertisements. The fabric includes a yarn woven into the fabric with a whiteness of at least greater than 90%, in which the yarn is composed of fibers made from a white masterbatch. A  manufacturing method of a fabric suitable for an inner light cloth of advertisements is also provided.
Patent CA-3158345-A1 (CA)
Inventor: SOKOL IVAN ALEXANDROVICH
IPC: G02F1/153
Filed: 2019-10-18
Abstract: L'invention concerne des dispositifs électrochromes et des composants de ceux-ci, ainsi que des systèmes et des procédés de commande de dispositifs électrochromes. En outre, des substances électrochromes, des compositions électrochromes et des couches électrochromes utiles pour les dispositifs et les systèmes peuvent se présenter sous la forme d'un gel. La présente invention concerne également des procédés de fabrication de dispositifs électrochromes et de composants associés, de compositions électrochromes, de couches et de gels.
Patent CA-3158472-A1 (CA)
Inventor: LOBB RICHARD
IPC: G01N33/48
Filed: 2020-10-26
Abstract: The present disclosure relates to the field of cancer. More particularly, the invention relates to methods of diagnosing and treating cancer, including determining a cancer type thereof. These methods involve the detection of markers in an exosome sample of the subject.
Patent CA-3159758-A1 (CA)
Title: Automated total nail care systems, devices and methods
Inventor: SHASHOU ALEXANDER
IPC: A45D29/00
Filed: 2020-10-29
Abstract: A system, device and method for nail care is provided. The nail care system includes a shaping system, a polish removal system and/or a cuticle management system; a vision system; a nail polish application system; and a mobility system. The nail system may further include an accelerated drying system, a hand massage system, a nail identification/diagnosis/estimation of conditions system, an enclosure, a hand/foot rest system, a computer software system, a computer hardware system, a cartridge/pod system, and a multi-tool system. Related apparatuses, techniques and articles are also described.
Patent CA-3159938-A1 (CA)
Inventor: BOT ADRIAN
IPC: A61K35/17
Filed: 2020-11-06
Abstract: La présente invention concerne des procédés de préparation, de production, de traitement, de culture, d'isolement ou de fabrication de cellules appropriées pour une thérapie immunitaire ou cellulaire, ainsi que des procédés d'utilisation correspondants en thérapie cellulaire.
Patent CA-3160454-A1 (CA)
Inventor: JOHNSON SAVANNAH
IPC: A24B13/00
Filed: 2020-12-08
Abstract: The disclosure provides a pouched product including a chromogenic material or an electronic component, wherein the chromogenic material and the electronic component are responsive to a stimulus. Such products can be employed to detect various changes associated with the pouched product.
Patent CA-3163607-A1 (CA)
Title: Urine collection system including a sizing device cross-reference to related applications
Inventor: MYERS BENJAMIN
IPC: A61F5/44
Filed: 2020-12-30
Abstract: Examples relate to devices, systems, and methods for fluid collection such as urine. A urine collection system (100) includes a urine collection device (102) and a sizing device (150) secured or securable to the urine collection device (100). The sizing device (150) includes a body (152) and a recess (185). The body (152) has a distal end (160) and an attachment end (155) distal to the distal end (160). The attachment end (155) defines an opening (180), and the recess (185) extends into the body (152) from the opening (180). The recess (185) is sized and dimensioned to receive a portion of the urine collection device (102) and secure the sizing device (150) to the urine collection device (102).
Patent CA-3167104-A1 (CA)
Inventor: BJORKLUND PETER
IPC: D21B1/36
Filed: 2021-01-25
Abstract: A method and system for recovery of energy from a continuously operated steam explosion reactor (218) for production of biomass pellets or briquettes, said method comprising the steps of: - condensing a blow-steam from the steam explosion reactor (218) for receiving a blow-steam condensate; - recovering heat from said condensation of the blow-steam to energise a fractionation system (300b), in which fractionation system volatile hydrocarbon compounds are recovered from said blow-steam condensate; and- recovering heat from said fractionation system (300b) for drying of biomass used in the steam explosion reactor (218).
Patent CA-3169724-A1 (CA)
Inventor: BOZA TRONCOSO AMERICO C
IPC: A01N25/30
Filed: 2021-02-26
Abstract: The present disclosure relates to micellar compositions conformed by biomimetic phospholipids and nonionic surfactants, among other ingredients, for eliminating one or more types of microorganisms including mycobacteria, bacteria, fungi, and viruses from a surface within a contact time on the surface of less than about 1 minutes and having pH of from about 0.3 to 8. The present invention aims on using 100% bio-based (renewable) biodegradable, non-toxic ingredients to be applied not only to hard inanimate surfaces but also on tissue for endodontic applications.
Patent CA-3170706-A1 (CA)
Title: Chimeric antigen receptors with cd28 mutations and use thereof
Inventor: DANIYAN ANTHONY
IPC: A61P35/00
Filed: 2021-02-05
Abstract: The present disclosure provides methods and compositions for enhancing the immune response toward cancers and pathogens. It relates to chimeric antigen receptors (CARs) comprising a mutated CD28 intracellular motif, and cells comprising such CARs. The presently disclosed subject matter further relates to the use of said cells for treating diseases, e.g, for treating cancers.
Patent CA-3175150-A1 (CA)
Inventor: RUAN FUQIANG
IPC: A61P17/00
Filed: 2021-03-11
Abstract: L'invention concerne des composés de formule (Ia), (Ib) et (IIa), et des sels pharmaceutiquement acceptables de ceux-ci. L'invention concerne en outre des compositions et des compositions pharmaceutiques comprenant les composés, des méthodes thérapeutiques les utilisant permettant de moduler (par exemple, inhiber) la signalisation médiée par la protéine de liaison à CREB (CBP)/ß-caténine dans le traitement d'un état de santé, d'une maladie ou d'un trouble (par exemple, une fibrose, un cancer, des états neurologiques, des troubles métaboliques (par exemple, le diabète, etc.), et des affections cutanées (dermatite, psoriasis, cicatrice, alopécie, etc.)) médiés par une signalisation de CBP/ß-caténine aberrante, et des méthodes cosmétiques pour traiter des affections cutanées (par exemple, le vieillissement, etc.). L'invention concerne en outre des méthodes permettant d'améliorer l'efficacité d'un vaccin faisant appel à des composés et des compositions. L'invention concerne en outre des procédés de synthèse efficace d'un médicament de qualité clinique, comprenant l'utilisation, dans une avant-dernière étape ou dernière étape de réaction dans des conditions de BPF, d'un composé 2-propynyle intermédiaire pour former un dérivé d'isoxazole de qualité clinique (par exemple, par l'intermédiaire d'une cycloaddition 3+2).
Patent CA-3179555-A1 (CA)
Title: Formulations pharmaceutiques
Inventor: BEJOT ROMAIN
IPC: A61K51/04
Filed: 2021-04-09
Abstract: La présente invention se rapporte à une composition pharmaceutique comprenant un agent radiohybride contenant un fluorure de silicium et un groupe chélateur, le fluor étant 18F ou le groupe chélateur contenant un métal radioactif chélaté, la composition ayant un pH de 4,0 à 6,0 et comprenant en outre : 0,1-200 mM de tampon citrate ; 1-100 mg/mL d'éthanol ; et 5-10 mg/mL de chlorure de sodium.
Patent CA-3183328-A1 (CA)
Inventor: YU CHANGQING
IPC: B25J5/00
Filed: 2022-12-02
Abstract: La présente divulgation concerne un poste déchange de batterie mobile dun seul côté. Des roues sont installées sur un châssis. Un compartiment déquipement doté de batteries est fixé au-dessus du châssis. Une partie coulissante est connectée de manière coulissante au compartiment déquipement. Un premier démultiplicateur est fixé à la partie coulissante, et un arbre de sortie est gainé et fourni de manière fixe avec un engrenage engagé avec une baie dans le compartiment déquipement. Un premier vérin télescopique est fixé de manière respective à la partie coulissante et à un deuxième démultiplicateur. Un arbre de sortie du deuxième démultiplicateur est fixé à une pièce de serrage au moyen dune pièce télescopique transversale. La pièce de serrage est connectée de manière amovible aux piles.
Patent CA-3188223-A1 (CA)
Inventor: YOU CHANGCHENG
IPC: A61L27/54
Filed: 2018-04-20
Abstract: This disclosure describes, inter alia, materials, devices, kits and methods that may be used to treat chronic sinusitis. An implant is configured to fit inside of the middle meatus of a human nasal cavity. The implant includes a therapeutic-agent formulation containing a layer of over 2000 micrograms of mometasone furoate. The implant releases the mometasone furoate for more than 12 weeks. A second implant can also be provided configured to fit inside the middle meatus. The second implant also includes a therapeutic-agent formulation containing a layer of over 2000 micrograms of mometasone furoate, and releases the mometasone furoate for more than 12 weeks.
Patent CA-3188785-A1 (CA)
Title: Camera de fond d'oeil hyperspectral non mydriatique
Inventor: HADOUX XAVIER
IPC: G01J3/28
Filed: 2021-07-14
Abstract: Est décrit, un appareil d'imagerie de fond d'il (11) comprenant un module d'éclairage (140) et un module d'imagerie (141). Le module d'éclairage (140) comprend des sources de lumière (103, 104) configurées pour générer de la lumière à des longueurs d'onde dans une plage spectrale souhaitée. Un premier ensemble optique est prévu pour mettre en forme et diriger la lumière sur un il (102) d'un sujet. Un filtre passe-bande accordable (109) sélectionne un sous-intervalle de longueur d'onde dans la plage spectrale souhaitée. Le module d'imagerie (141) comprend un second ensemble optique pour collecter la lumière renvoyée par l'il (102) du sujet et pour projeter la lumière renvoyée de l'il (102) sur un capteur d'image (113). Le second ensemble optique comprend un ou plusieurs éléments optiques pouvant compenser une variation oculaire. Le capteur d'image (113) est configuré pour imager la lumière renvoyée afin de générer une image du fond d'il au niveau du sous-intervalle de longueur d'onde.
Patent CA-3188947-A1 (CA)
Title: Post-tensioned helical anchors simultaneously spin-drilled and grouted and method therefor
Inventor: HENDERSON ALLAN P
IPC: E02D5/56
Filed: 2023-02-08
Abstract: An assembly and method of simultaneously spin drilling and pressure grouting a helical anchor into the ground vertically, horizontally or at an inclined angle create a continuous grouting configuration inside and outside the helical anchor for its entire depth in the ground. The helical anchor is configured to be partially or completely removed as desired and can be provided at its upper end with a tensioning element to post tension a cementitious foundation structure. A unique spin drilling and grouting assembly continuously provides grout under pressure to the interior of the helical anchor during its spin drilling into the ground. In one embodiment, the pressure grouted helical anchor is used with an upwardly extending tensioning element to reinforce cementitious foundation caps or other concrete support foundations.
Patent CA-3191699-A1 (CA)
Title: Methods for target release from intein complexes
Inventor: RAMMO OLIVER
IPC: C12P21/02
Filed: 2021-09-27
Abstract: The present disclosure relates to methods of releasing a target molecule from intein complexes comprising an intein-C tagged target molecule and intein-N polypeptides, by contacting the intein complexes with nitrogen containing heteroaromatic derivatives, and/or by increasing residence time of intein complexes in a medium effective to remove the target molecule. Modulating the pH further facilitates target release.
Patent CA-3191958-A1 (CA)
Title: Imaging markers for verifying biometry
Inventor: CHARLES STEVEN T
IPC: G06T7/00
Filed: 2021-09-17
Abstract: The systems and methods described herein provide improved techniques for displaying imaging markers for verifying biometry. A method includes receiving an indication to initiate a first optical coherence tomography (OCT) scanning of an eye; initiating, based on the received indication, the first OCT scanning of the eye; generating, based on the first OCT scanning, a first OCT image of the eye; detecting, based on the first OCT image, a retinal pigment epithelium (RPE) and a fovea in the eye; based on the detecting, causing a first enhanced OCT image to be displayed to a user, the first enhanced OCT image displaying: a first virtual marker segmenting at least a portion of the detected RPE, and a second virtual marker, where the second virtual marker visually identifies a location of the detected fovea, and where the second virtual marker is a radial line through the location of the detected fovea.
Patent CA-3192982-A1 (CA)
Title: Dosage forms for tyk2 inhibitors comprising swellable cores
Inventor: KESTUR UMESH
IPC: A61P1/00
Filed: 2021-09-17
Abstract: A swellable core dosage form comprises a dispersion of amorphous 6-(cyclopropaneamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-(methyl-d3)pyridazine-3-carboxamide.
Patent CA-3193015-A1 (CA)
Inventor: KUKKONEN VIKTOR
IPC: C07D493/10
Filed: 2021-06-01
Abstract: L'invention porte sur des agents de marquage, y compris des monomères fluorescents, qui peuvent manquer de doubles liaisons polymérisables. L'invention porte également sur des compositions de polymère tartrifuges qui comprennent un copolymère d'un agent de marquage et d'un monomère tartrifuge. L'invention porte en outre sur des procédés de synthèse d'agents de marquage, de compositions de polymère tartrifuges, et de détection d'une composition de polymère tartrifuges.
Patent CA-3197675-A1 (CA)
Inventor: MCCREE JUSTIN
IPC: B65D71/42
Filed: 2021-09-28
Abstract: Un dispositif de transport pour contenir une pluralité de récipients comprend un panneau supérieur comprenant une pluralité d'ouvertures de retenue de récipient pour recevoir au moins partiellement un récipient respectif de la pluralité de récipients, au moins un rabat de retenue de récipient relié de façon pliable au panneau supérieur, le panneau supérieur comprenant au moins une languette de retenue de récipient positionnée à côté d'une ouverture de retenue de récipient respective et reliée de manière pliable au panneau supérieur au niveau d'une ligne de pliage respective, au moins un panneau de renfort latéral positionné entre le panneau supérieur et le rabat ou les rabats de retenue de récipient, le panneau supérieur comprenant au moins une partie de renfort s'étendant à partir de la ligne de pliage respective.
Patent CA-3198033-A1 (CA)
Title: Perforating gun assembly having detonator interrupter
Inventor: SULLIVAN SHELBY L
IPC: E21B43/1185
Filed: 2023-04-27
Abstract: A detonator interrupter assembly is provided. The detonator interrupter assembly is designed to inhibit the amiing of a detonator within the charge tube of a perforating gun assembly. The detonator interrupter assembly first includes a top end plate. The top end plate is configured to reside between charge tubes. The top end plate has a flange intermediate first and second ends. The detonator interrupter assembly also includes a detonator clip. The detonator clip resides proximate the second end of the top end plate. The detonator clip comprises a first slot configured to receive a detonator cord, and a second slot configured to receive a detonator tube which contains an explosive material. The detonator interrupter assembly also includes an interrupter. The interrupter comprises a handle portion and an opposing blade portion. The blade portion is configured to pass through a through-opening through the flange when an operator removes the interrupter from between the first and second slots. The blade portion is fabricated from an impact resistant material.
Patent CA-3202276-A1 (CA)
Inventor: POUPONNEAU PIERRE
IPC: A61B34/00
Filed: 2022-01-19
Abstract: A system (10) for moving an intravascular medical device (85) in a vascular network (V) comprises a magnetic actuator (40), a controlling unit (50) and a controlling line driver (60). The controlling line driver (60) is adapted to hold and/or to release a controlling line (70) attached to the medical device (85) at different speeds. The magnetic actuator is adapted to generate a magnetic field (41) at a predetermined location in order to pull the medical device (85) in a pre-determined direction. The controlling unit (50) is adapted to balance at least three forces applied on the medical device (85) and to operate the magnetic actuator (40) and/or the controlling line driver (60).
Patent CA-3204265-A1 (CA)
Title: Flow cytometry platform for the detection of glycosylated proteins in a clinical sample
Inventor: Capocasale Renold Julius
IPC: C07K14/00
Filed: 2022-01-05
Abstract: Described herein is a flow cytometry platform for the detection of glycosylated proteins in a clinical sample, along with the use of a flow cytometry platform for early disease diagnoses, for example, hepatocellular carcinoma (HCC). The use of the flow cytometry platform described herein allows for multiplexing and quantification of two or more biomarkers associated with the disease, for example, alpha-feto protein (AFP), alfa-feto protein-L3 (AFP-L3), or alpha-L-fucosidase (AFU) for HCC patients.
Patent CA-3205963-A1 (CA)
Inventor: SHOYKET VITALY
IPC: G06F16/41
Filed: 2023-07-10
Abstract: The method for storing streaming media includes receiving, from a user device, a request to navigate to a requested time of a media stream. The method also includes determining whether a block of media segments that have a time interval that overlaps with the requested time is stored at the server. The method also includes retrieving the block of media segments from long-tenn memory in accordance with a determination that the block of media segments is not stored at the server. The method also includes traversing the block of media segments that have a time interval that overlaps with the requested time of the media stream to seek and identify a media segment corresponding to the requested time of the media stream. The method also includes streaming a media stream to the user device that begins at the media segment corresponding to the requested time of the media stream.
Patent CA-3206335-A1 (CA)
Inventor: ROUX HAMEED SOFIA TALLULA
IPC: H02S30/10
Filed: 2023-07-06
Abstract: A photovoltaic system includes a frame configured to removably couple to a structure. A  first photovoltaic panel is coupled to a first portion of the frame, the first photovoltaic panel having a first side configured to face away from the frame, the first side comprising a first area of photovoltaic material. A second photovoltaic panel is movably coupled to a second portion of the frame, the second photovoltaic panel comprising a first side configured to face away from the frame, the first side of the second photovoltaic panel comprising a second area of photovoltaic material. A movement mechanism is coupled to the frame, the movement mechanism configured to cause the second photovoltaic panel to move between a first configuration and a second configuration.
Patent CA-3212711-A1 (CA)
Title: Procede, appareil et dispositif d'optimisation de configuration, et support de stockage lisible
Inventor: XIE FANG
IPC: H04W24/02
Filed: 2022-03-21
Abstract: Des modes de réalisation de la présente invention concernent un procédé, un appareil et un dispositif d'optimisation de configuration, et un support de stockage lisible. Le procédé comprend les étapes suivantes : un dispositif côté réseau configure un terminal pour rapporter des informations concernant un transfert conditionnel (CHO) ou un ajout/changement de PSCell conditionnel (CPAC), de telle sorte que le dispositif côté réseau peut effectuer une optimisation de configuration CHO et/ou une optimisation de configuration d'accès aléatoire.
Patent CA-3213240-A1 (CA)
Title: Composition anticorrosion
Inventor: HAMZA OSAMA
IPC: C03C13/06
Filed: 2022-03-24
Abstract: La présente invention concerne une composition anticorrosion et l'utilisation d'une telle composition pour conférer des propriétés anti-corrosion à un matériau, ainsi qu'un matériau comprenant une telle composition.
Patent CA-3213875-A1 (CA)
Inventor: WAJANT HARALD
IPC: C07K16/28
Filed: 2022-04-01
Abstract: The present disclosure provides a binding molecule that specifically binds TNFR2, but not TNFR1. Preferably the binding molecule is an FcyR-independent agonist of TNFR2 and more preferably has a valency of at least two for binding TNFR2. The binding molecules have a variety of uses including diagnostic and therapeutic. The ability of the binding molecules to be able to modulate immune responses means that they are particularly suited for treating autoimmune diseases, or inflammatory conditions.